Navigation Links
Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
Date:5/16/2008

ies and risks. All statements regarding future performance, earnings projections, regulatory approval, events or developments are forward-looking statements. It is possible that the future performance of the company may differ materially from current expectations, depending on economic conditions and the uncertainty of regulatory approval. A change in economic conditions may have a particularly volatile effect on results. Among the other factors which may affect future performance are: competitive market conditions and resulting effects on sales and pricing; increases in raw-material costs that cannot be recovered in product pricing; and global economic factors, including difficulties entering new markets and general economic conditions such as inflation, interest rates and credit availability. The company makes these statements as of the date of this disclosure, and undertakes no obligation to update them.


'/>"/>
SOURCE Pulmo BioTech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension
2. PulmoBioTech Announces Details of Its Regulatory Approval Experiments
3. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
4. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
5. Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease
6. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
7. Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension
8. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
9. Strykers Biotech Division Receives FDA Warning Letter
10. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
11. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...TON, Calif., Oct. 10 /- TriReme Medic...horized to affix the CE (Conformite,Europeenne) ma...Coronary,Stent System, a unique main vessel stent ...ary bifurcations., Representing the next generati... has potential use in a quarter of the 2.2 million...
(Date:10/9/2008)...ight Day 2008 focuses on the need to protect the e...wire/ -- Of the 45 million people worldwide who,ar...rters of them could,have avoided their blindness i...o view the Multimedia News Release, go to:, http:/... world,s leader in eye care products and equipment...
(Date:10/9/2008)...e Clinical Results Expected in November 2008, BOT...R Pharma, Inc.,(Amex: DDD ) announced today the c... third of its three pivotal trials to evaluate the... extended-release (ER) ibuprofen for,the over-the-...t top-line,results from this pivotal trial in Nove...
(Date:10/9/2008)...LM, October 9 /- Diamyd Med...ical journal, the New England Journal,of Medicine,...mpany,s study,of the Diamyd(R) diabetes vaccine fo...m/cgi-bin/prnh/20080314/297194 ), The article is...www.nejm.org ) and will be in print on October 30....
Breaking Medicine Technology:TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Poverty Drains Nutrition From Family Diet 12398 1Poverty Drains Nutrition From Family Diet 12398 2Poverty Drains Nutrition From Family Diet 12398 3First Lady Laura Bush Visits AED Netmark Malaria Control Project in Ghana 12394 1First Lady Laura Bush Visits AED Netmark Malaria Control Project in Ghana 12394 2Yoga Journal Circulation Increases 5 8 Percent in Second Half of 2007 from Same Period Previous Year 12390 1Yoga Journal Circulation Increases 5 8 Percent in Second Half of 2007 from Same Period Previous Year 12390 2Emageon Reports Fourth Quarter and 2007 Financial Results 12386 1Emageon Reports Fourth Quarter and 2007 Financial Results 12386 2Emageon Reports Fourth Quarter and 2007 Financial Results 12386 3Emageon Reports Fourth Quarter and 2007 Financial Results 12386 4Emageon Reports Fourth Quarter and 2007 Financial Results 12386 5Emageon Reports Fourth Quarter and 2007 Financial Results 12386 6Emageon Reports Fourth Quarter and 2007 Financial Results 12386 7Emageon Reports Fourth Quarter and 2007 Financial Results 12386 8Emageon Reports Fourth Quarter and 2007 Financial Results 12386 9
...07-AstraZeneca today announced clinical,trial data...apine,fumarate sustained release), at the European...demonstrated that the SEROQUEL®,sustained rele...ease), administered once daily, significantly impr...red by PANSS) and increased the,time to psychiatri...
...S WIRE)--Mar 20, 2007 - MGI PHARMA, INC.,(NASDAQ: ...logy and,acute care, today announced that a random...trial of Aquavan(R) (fospropofol,disodium) Injecti...y successfully met its primary endpoint of sedatio...g patients who,received an initial bolus dose of 6...
Other Medicine Technology:Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 2Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 3Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 4MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 2MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 3MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 4MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 5MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 6
(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...fare, Indian scientists have been sequencing the g...It is India's first sequencing effort of a complet...several diseases, including tuberculosis and lepro...de from killed Mw drastically reduces treatment ti...
...fer from migraine are more at risk of heart attack...ological condition, of which the most common sympt... Men with migraines were more likely to have high...d cholesterol levels, compared to men who didn't h...
...a bacterium, which is one of the leading cause for...ing cause for blindness globally, is said to be// ...ve imagined. The scientists from Children’s Hospi...ere the first to conclude this with the help of a ...
...two important changes that revolve around prematur...ch-greater ability of medical advances to keep// a...nge that has been noted is the increased rate of p...e births resulting from fertility treatment. A re...
Other Medicine News:Health News:India Finds New Use for an Old Bug 2Health News:India Finds New Use for an Old Bug 3Health News:Newly Identified Strains Of Chlamydia Trachomatis – A Gateway To New Disease 2Health News:Premature Babies- What should be done about them? 2
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: